Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates

International Dairy Journal

Volumn 25, Issue 2, 2012, Pages 97-102

  Lacroix, Isabelle M E ^a   Li Chan, Eunice C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE; ENZYMATIC TREATMENTS; IN-VITRO; INHIBITORY ACTIVITY; MILK PROTEIN; NATURAL SOURCES; PROTEIN HYDROLYSATE; SKIM MILK POWDER; SODIUM CASEINATE; SYNTHETIC DRUG; TYPE-2 DIABETES; WHEY PROTEIN ISOLATE;

HYDROLYSIS; SODIUM;

DAIRIES;

EID: 84861332110     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2012.01.003     Document Type: Article

References (29)

1. Adler-Nissen J. Enzymic hydrolysis of food proteins (pp. 9--24) 1986, Elsevier Applied Science Publishers, New York, NY, USA.
2. Bella A.M., Erickson R.H., Kim Y.S. Rat intestinal brush border membrane dipeptidyl-aminopeptidase IV: kinetic properties and substrate specificities of the purified enzyme. Archives of Biochemistry and Biophysics 1982, 218:156-162.
3. Cohen M., Fruitier-Arnaudin I., Piot J.M. Hemorphins: substrate and/or inhibitors of dipeptidyl peptidase IV Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV. Biochimie 2004, 86:31-37.
4. Cunningham D.F., O'Connor B. Proline specific peptidases. Biochimica et Biophysica Acta 1997, 1343:160-186.
5. Dziuba M., Dziuba B., Iwaniak A. Milk proteins as precursors of bioactive peptides. Acta Scientiarum Polonorum Technologia Alimentaria 2009, 8:71-90.
6. FitzGerald R.J., Murray B.A. Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 2006, 59:118-125.
7. Garrett D.A., Failla M.L., Sarama R.J. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. Journal of Agricultural and Food Chemistry 1999, 47:4301-4309.
8. Hernández-Ledesma B., Recio I., Amigo L. β-Lactoglobulin as source of bioactive peptides. Amino Acids 2008, 35:257-265.
9. Hernández-Ledesma B., Recio I., Ramos M., Amigo L. Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. International Dairy Journal 2002, 12:805-812.
10. Holst J.J., Deacon C.F. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Current Opinion in Pharmacology 2004, 4:589-596.
11. Hunziker D., Hennig M., Peters J.-U. Inhibitors of dipeptidyl peptidase IV - recent advances and structural views. Current Topics in Medicinal Chemistry 2005, 5:1623-1637.
12. Korhonen H. Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 2009, 1:177-187.
13. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16:945-960.
14. Lacroix M., Bos C., Léonil J., Airinei G., Luengo C., Daré S., et al. Compared with casein or total milk protein, digestion of milk soluble proteins is too rapid to sustain the anabolic postprandial amino acid requirement. American Journal of Clinical Nutrition 2006, 84:1070-1079.
15. Lacroix, I. M. E., & Li-Chan, E. C. Y. (2012). Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. Journal of Functional Foods, submitted for publication doi:10.1016/j.jff.2012.01.008.
16. Lambeir A.-M., Durinx C., Scharpé S., De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on the structural properties, functions, and clinical aspects of the enzyme DPP IV. Clinical Reviews in Clinical Laboratory Sciences 2003, 40:209-294.
17. Lo W.M.Y., Li-Chan E.C.Y. Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. Journal of Agricultural Food Chemistry 2005, 53:3369-3376.
18. Lorey S., Stöckel-Maschek A., Faust J., Brandt W., Stiebitz B., Gorrell M.D., et al. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites. European Journal of Biochemistry 2003, 270:2147-2156.
19. Mentlein R. Therapeutic assessment of glucagons-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. Expert Opinion on Investigational Drugs 2005, 14:57-64.
20. Nelson D.L., Cox M.M. Amino acids, peptides and proteins. Lehninger principles of biochemistry 2008, 71-112. W.H. Freeman, New York, NY, USA.
21. Otte J., Shalaby S.M., Zakora M., Pripp A.H., El-Shabrawy S.A. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 2007, 17:488-503.
22. Rahfeld J., Schierhorn M., Hartrodt B., Neubert K., Heins J. Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?. Biochimica et Biophysica Acta 1991, 1076:314-316.
23. Sebokova E., Christ A.D., Boehringer M., Mizrahi J. Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes. Current Topics in Medicinal Chemistry 2007, 7:547-555.
24. Segura-Campos M., Chel-Guerrero L., Betancur-Ancona D., Hernandez-Escalante V.M. Bioavailability of bioactive peptides. Food Reviews International 2011, 27:213-226.
25. Thoma R., Löffler B., Stihle M., Huber W., Ruf A., Hennig M. Structure basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 2003, 11:947-959.
26. Van Amerongen, A., Beelen-Thomissen, M. J. C., Van Zeeland-Wolbers, L. A. M, Van Gilst W. H., Buikema, J. H., & Nelissen. J. W. P. M. (2009). Egg protein hydrolysates. Int. Pat. No. WO 2009/128713 A1.
27. Walter R., Simmons W.H., Yoshimoto T. Proline specific endo- and exopeptidases. Molecular and Cellular Biochemistry 1980, 30:111-127.
28. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates from the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
29. Yan T.-R., Ho S.-C., Hou C.-L. Catalytic properties of X-prolyl dipeptidyl aminopeptidase from Lactoccocus lactis subsp. cremoris nTR. Bioscience, Biotechnology, and Biochemistry 1992, 55:704-707.